NeuroBo Completes First Phase 1 Enrollment for Obesity Drug Trial – TipRanks

Related posts:

1. ESMO Magnitude of Clinical Benefit Scale assists oncology clinicians in evaluating anti-cancer medicines ESMO, the European Society for Medical Oncology, has announced today the publication of the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS), a tool to assist oncology clinicians in evaluating the most effective anti-cancer medicines for their patients. ...
2. CA Surgeon General, “Screen Every Student for Childhood Trauma” Childhood Trauma is the elephant in the room, people. California, often the leader n social […] ...
3. Anticoagulant medications: Newer, easier to manage medications may not always be the best choice If you are over age 75, and taking an anticoagulant, the old standard may be the gold standard, Mayo Clinic researchers and collaborators have determined. ...
4. Ossur to announce clinical trials for implanted myoelectric sensors for brain-controlled prosthetics Ossur, an Icelandic based prosthetics development company is set to announce the beginning of clinical trials for its Proprio foot, a new kind of brain controlled prosthetic ankle and foot. Instead of trying to connect the device to nerves, the robotic limb uses sensors to detect nerve signals in muscles near the point where the limb was removed. The limb then analyses those signals and converts them to movement in real time, which is reportedly very close to that of natural limbs. ...
5. what to know about the latest COVID variants on the rise We’re in the midst of a bad cold and flu season in Australia. Along with […] ...